Download presentation
Presentation is loading. Please wait.
1
NA or other NANC 5HT 3 - ACh + - + 5HT 4 5HT 1or2 5-HT + + + ACh Enk + ,, - - DA - D2 PERISTALTIC REFLEX Proximal Contraction Distal Relaxation WATER EXCRETION
2
NA or other ACh + - Water Excretion Motility ACh + X
3
+ Motility Don’t forget hormone actions esp. motilin, somatostatin
4
ACh + DA - D2
5
ACh + DA - D2 METOCLOPRAMIDE X
6
+ 5HT 4 ACh NANC 5HT 3 - ACh + 5-HT + + PERISTALTIC REFLEX Proximal Contraction Distal Relaxation
7
+ 5HT 4 ACh + CISAPRIDE TEGASEROD (5HT 4 agonists)
8
NANC 5HT 3 - ACh + 5-HT + ONDANSETRON ALOSETRON (5HT 3 antagonists) X INCREASED CONTRACTION BUT DECREASED MOTILITY!
9
ACh + Enk ,, - -
10
ACh + Enk NA or other - 5HT 1or2 5-HT + Enk + ,, - - + inhibition of 5-HT mediating segmentation (not shown)
11
NA or other ACh + - 5HT 1or2 5-HT + ,, DIPHENOXYLATE LOPERAMIDE
12
NA or other NANC 5HT 3 - ACh + - + 5HT 4 5HT 1or2 5-HT + + + ACh Enk + ,, - - DA - D2 METOCLOPRAMIDE is a DA antagonis that acts as cholinomimetics to increase motility DIPHENOXYLATE & LOPERAMIDE are opioids that decrease motility and reduce secretion CISAPRIDE and TEGASEROD are 5Ht4 agonist s that increase motility The “SETRONS”are 5Ht3 antagonist s that inhibit peristalsis ALVIMOPAN and METHYLNALTREXONE are opioid receptor antagonists that increase motility and increase secretion
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.